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Abstract
The human vaginal microbiome plays a critical but poorly defined role in reproductive health. Vaginal microbiome
alterations are associated with increased susceptibility to sexually-transmitted infections (STI) possibly due to related
changes in innate defense responses from epithelial cells. Study of the impact of commensal bacteria on the vaginal
mucosal surface has been hindered by current vaginal epithelial cell (VEC) culture systems that lack an appropriate interface
between the apical surface of stratified squamous epithelium and the air-filled vaginal lumen. Therefore we developed a
reproducible multilayer VEC culture system with an apical (luminal) air-interface that supported colonization with selected
commensal bacteria. Multilayer VEC developed tight-junctions and other hallmarks of the vaginal mucosa including
predictable proinflammatory cytokine secretion following TLR stimulation. Colonization of multilayers by common vaginal
commensals including Lactobacillus crispatus, L. jensenii, and L. rhamnosus led to intimate associations with the VEC
exclusively on the apical surface. Vaginal commensals did not trigger cytokine secretion but Staphylococcus epidermidis,a
skin commensal, was inflammatory. Lactobacilli reduced cytokine secretion in an isolate-specific fashion following TLR
stimulation. This tempering of inflammation offers a potential explanation for increased susceptibility to STI in the absence
of common commensals and has implications for testing of potential STI preventatives.
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Introduction
The human vaginal mucosa is composed of a non-keratinized
stratified squamous epithelium that forms a natural barrier to
pathogens [1,2]. This specialized epithelium has distinctive
architectural features including basal cells serving as progenitors
for the apical layers that are often anucleate, elongated and
frequently are sloughed into the vaginal cavity [3,4]. The
intermediate cell layers contain substantial amounts of glycogen
and mucins that localize to vacuoles also present in basal cells
[2,4,5]. Also, tight junction complexes are a hallmark of the
vaginal mucosa [6]. Under specific conditions, the permeability of
these complexes is altered to permit passage of innate immune
effector molecules secreted by the vaginal epithelial cells (VEC).
The commensal microflora have been increasingly recognized
as an important component of the vaginal mucosal defense against
STI [7]. Several different species of commensal bacteria including
species from the genera Lactobacillus, Corynebacterium, Pre-
votella and Peptostreptococcus have been identified commonly in
vaginal specimens [7,8,9,10,11]. These commensal organisms are
intimately associated with VEC and play crucial but poorly
defined roles in vaginal health [12]. In healthy women, the most
prevalent commensal Lactobacilli are L. crispatus, L. iners, L. jensenii
and L. rhamnosus [7,11]. Interestingly, L. iners also was associated
with recovery states following cessation of antimicrobial therapies
[10,13]. Lactobacilli have several important roles for maintaining
a healthy vaginal environment including the constitutive produc-
tion of antimicrobial agents and reducing the extracellular pH of
the vaginal mucosa through lactic acid production [7]. It is
believed that commensal organism metabolism of the abundant
glycogen stores present in VEC in vivo facilitates the symbiotic
relationship helping to provide a uniform physical barrier against
pathogen adhesion and establishment of infection [2,4,7,14,15].
Clinically, the loss of vaginal Lactobacilli due to antibiotic therapy,
douching, sexual activity, pathologies or other factors is associated
with increased susceptibility to subsequent infection [7,12,16,17].
It is of substantial importance then that a relevant and effective
model system be developed to allow study of the molecular
interactions between human VEC and a microbiome.
Several promising topical agents designed to reduce or prevent
experimental STI transmission have proven successful in clinical
trials [18,19,20]. The previous clinical failures and inadequate
predictions of a topical compound’s potential may have been
precipitated by unintended alterations of the vaginal bacterial
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We posit that such alterations also may impact any commensal-
associated modulation of innate immune responses elicited by
VEC following vaginal application of topical therapies. A human
culture system that addresses the impact of common vaginal
commensals should help to define the role of these bacteria in
vaginal defense and allow for better predictions of clinical
outcomes and priorities for clinical testing of promising topical
preventative compounds. To this end, we have generated a highly
reproducible system, utilizing immortalized cells from 3 donors
[21], that form multilayer VEC cultures with an apical air
interface modeling the surface of the vaginal mucosa. These
multilayer VEC were architecturally similar to the human vaginal
mucosa and supported sustained apical colonization by selected
common commensal bacteria. Using these cultures we have shown
that lab-adapted and clinical isolates of L. crispatus, L. jensenii and L.
rhamnosus play an active role in the modulation of the magnitude of
cytokine responses in patterns that are distinct from other
Lactobacillus spp or other less common vaginal bacteria species.
This is the first direct evidence for a molecular contribution of
Lactobacilli to vaginal health and suggests a much broader role for
these bacteria in the dynamic functions of this mucosa. Further
study of this model system will allow the identification of the key
molecular interactions between the commensal bacteria and the
human VEC that lead to enhanced vaginal health and increased
resistance to STI. Such studies should reveal novel probiotic
approaches to limit infections by human pathogens including
HIV.
Results
Immortalized human vaginal epithelial cells (VEC) formed
multilayer cultures consistent with stratified squamous
epithelia
To enhance the quality of human vaginal culture models,
immortalized VEC from one of three donors were seeded into
transwell culture inserts. After 48 h, the growth medium was
removed from the apical chamber forming an air-interface. Trans-
epithelial electrical resistance (TEER) monitoring of VEC
multilayers, temporarily covered in PBS, significantly (p,0.001)
increased by day 7–9 (avg.=228.966.4 Vcm
2) relative to TEER
values at seeding (day 0 avg.=41.460.3 Vcm
2) and were
maintained through d14. To address histological characteristics,
established multilayers (day 9) on the filter support were fixed and
then carefully excised from the inserts for paraffin embedding.
Hematoxylin and eosin (H&E) stained cross sections showed that
VEC from each of the 3 donors formed multiple cell layers with
nucleated cells at the basolateral surface and elongated, often
anucleate cells at the apical surface (Figure 1A). These observa-
tions were consistent with histological sections obtained from
human vaginal mucosal biopsies [3,5]. Periodic acid Schiff (PAS)
staining of sequential multilayer culture sections showed substan-
tial glycogen stores were present at intracellular sites (Figure 1B)
similar to those observed in normal vaginal tissue [2,4,6]. In
conjunction with confocal and transmission electron microscopy
(EM) the H&E staining images reproducibly indicated that the
VEC multilayers were composed of 7–12 cell layers (avg. thickness
of 4869 um) 7–9 d after seeding.
Transmission EM evaluations of day 9 cultures illustrated that
VEC contained large numbers of vacuoles (Figure 1C). Basal and
intermediate cells contained large vacuoles while smaller vacuoles
were observed in the elongated, often anucleate apical cells
(Figure 1C) that labeled positively for glycogen (Figure 1B) or
mucins (data not shown). TEM also indicated the presence of tight
junction complexes between the plasma membranes of cells
(Figure 1D). Immunogold-labeling for the tight junction protein
occluding [22], confirmed the identity of these structures
(Figure 1E). Secondary antibody alone did not label the structures
in subsequent sections (Figure 1E, insert). With regard to
reproducibility, VEC multilayers established with cells from any
of the three donors produced indistinguishable micrographs (data
not shown) indicating that immortalized VEC under our culture
conditions reproducibly formed multilayer cultures with apical air-
interfaces that architecturally modeled the human vaginal mucosa.
VEC multilayer cultures responded to selected TLR
agonists
To evaluate innate responses of VEC multilayers, cultures
were treated apically with a panel of TLR agonists previously
tested in standard culture format [21]. Specifically, PIC (TLR3),
FSL-1 (TLR2/6), FLAG (TLR5) and PGN (TLR2) were tested
because they are recognized by the most abundantly expressed
TLRs in human VEC [21]. VEC multilayers established with
cells from each of three donors produced similar TLR agonist-
induced cytokine profiles consistent with our previous findings
in standard culture formats [21]. Application of PIC, a synthetic
Figure 1. Human immortalized VEC differentiated into multi-
layers with air-interfaces morphologically similar to vaginal
stratified squamous epithelium. A. A representative H&E (4006)
staining of a d 9 V19I VEC multilayer 5 um section that illustrates the
formation of multiple cell layers. The transwell porous membrane can
be seen at the bottom of the micrograph. B. PAS staining of a 5 uM
section through a VEC multilayer illustrated the substantial amounts of
glycogen produced. VEC grown in standard format did not stain by PAS
(data not shown). C. A representative transmission EM image of a d 9
V19I VEC multilayer culture (.7 layers) including the transwell porous
support (bottom) and the apical anucleate layers sloughing from the
top surface (bar=10 uM). The micrograph illustrates the intracellular
structures and the formation of tight junctions indicating full
polarization and differentiation. D. Tight junction complexes (white
arrows) were observed between the plasma membranes of VEC within
7–9 d of plating (bar=100 nm) and were confirmed, E., by immuno-
gold labeling for occludin (black arrows show gold particle deposition;
bar=100 nM). Inset panel: A secondary antibody control transmission
EM showed no labeling at the tight junction complexes (black arrows,
bar=100 nM).
doi:10.1371/journal.pone.0032728.g001
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significant (p,0.05) secretion of IL-1ra, IL-6, IL-8, GM-CSF,
MIP-1b, RANTES and TNFa at 6 h post application compared
to parallel cultures treated with vehicle only (Table 1). FSL-1, a
bacterial-derived TLR2/6 agonist, elicited a distinct cytokine
profile with significant (p,0.05) increases in IL-6, IL-8, IL-
12(p70), G-CSF, GM-CSF, MIP-1b, RANTES and TNFa
relative to vehicle alone (Table 1). The addition of other
bacterial-derived agonists, recognized through different TLR,
led to significant (p,0.05) elaboration of IL-6, IL-8, G-CSF,
MIP-1b and TNFa for FLAG (TLR5) and IL-1b, IL-1ra and
TNFa for PGN (TLR2) (Table 1). The observed agonist-specific
cytokine profiles were consistent with our previously reported
findings from standard culture formats [21] and indicated that
multilayer VEC responded to TLR agonists. Of the 4 tested
agonists, PIC and FSL-1 produced the most robust cytokine
induction with common significant increases in IL-6, IL-8 and
TNFa. For the remaining studies, r e s u l t sf o rc y t o k i n e si n d u c e d
by PIC or FSL-1 will be presented.
Commensal bacteria colonized the apical surface of
human VEC multilayer cultures
Having established basic morphological and immunological
characteristics of VEC multilayer cultures, the ability of the model
to support common vaginal commensal bacteria (L. crispatus or L.
jensenii) colonization was evaluated. As an initial qualitative
evaluation of colonization, bacterial adherence as well as potential
inappropriate penetration into the VEC multilayers was analyzed
via EM and confocal microscopy (Figure 2). Transmission EM
analyses confirmed the presence of rod-shaped Lactobacilli (L.
jensenii shown) tightly associated with VEC exclusively on the
apical surface of each multilayer examined (Figure 2A, electron
dense rods shown in cross section). These transmission EM
micrographs also indicated that apical cells appeared intact and
contained multiple glycogen vacuoles, tight junctions and
multilayer architecture similar to non-colonized cultures that were
seeded at the same time and processed in parallel.
Scanning EM provided additional imagery to illustrate the
location and associations of the bacteria with the apical VEC. In
most fields, the bacteria were in direct contact with microvilli-like
structures on the apical most cells and were distributed relatively
evenly across the surface (Figure 2B and C). The average length of
L. jensenii in contact with VEC, calculated by measuring bacteria
from 33 fields, was 1.45 um60.08 um. Similar sizes were observed
for L. crispatus that were inoculated onto parallel VEC cultures
(data not shown). Interestingly, bacteria were not observed to
attach to the VEC that were anucleate with ruffled membranes
consistent with a detachment process seen in mucosal sloughing
(Figure 2C left side of the micrograph).
Importantly, both transmission and scanning EM showed no
penetration of Lactobacilli into deeper layers and no intracellular
bacteria were observed in any sections (.50 examined) from
colonized multilayers established from all three donors. Apical
surface localization was confirmed using GFP-expressing VEC
multilayers and confocal microscopy. GFP-VEC were seeded with
L. jensenii, cultured for 24 or 72 h and then fixed and
immunolabeled to localize the bacteria. Optical sectioning
through the culture confirmed that the bacteria did not penetrate
into the multilayers as evaluated by multiple compiled Z-stacks
(Figure 2D top panel). Individual slices showed that bacteria
localized to apical surfaces with some pooling in the valleys that
formed in each culture (Figure 2D, lower panel).
The surface area of the multilayer cultures in 96 well format was
determined to be 80 mm
2 representing ,0.1% of the human
vaginal mucosal surface [6]. Based on this calculation, we
estimated that an effective model system should be colonized by
a bacterial population of #10
6 viable organisms based on reported
levels of vaginal Lactobacilli spp colonization (10
9 bacteria) [8]. In
preliminary studies, we established that multilayers seeded with
10
3 viable bacteria created a stable bacterial load of 10
5 colony-
forming units (cfu) within 24 h. To quantify the viable bacterial
titers in colonized cultures at later time points, we adapted the
standard serial dilution quantification method with agar plates to a
higher-throughput, broth-based, 96-well plate format and con-
firmed its validity by comparison for both L. jensenii and L. crispatus
Table 1. TLR agonists induced specific cytokine profiles in VEC multilayer cultures.
Cytokine
b Medium ctrl TLR Agonists
a
PIC FSL-1 FLAG PGN
IL-1b 12631 8 611 1 619 625 8 69
e
IL-6 1161 1057663
e 155617
d 13767
e 964
IL-8 96611 2486368773
c 2486768769
c 1925862566
d 6476206
IL-12(p70) 40644 2 635 7 64
c 42643 4 65
TNFa 18624 6 0 63
e 263614
e 434633
e 2962
d
G-CSF 58616 4664 524629
e 1002688
e 1365
GM-CSF 9612 5 62
e 2364
d 3967
d 561
MIP-1b 5624 1 61
e 13863
e 2867
d 361
RANTES 55621 313611
e 30262
e 78610 62615
IL-1ra 984461943 4275763225
e 1306062479 819861313 8623665018
e
aPIC (0.1 mg/mL), FSL-1 (0.1 ug/mL), FLAG (5 ug/mL), PGN (0.1 mg/mL) or a medium control (ctrl, 10 uL) was added to the apical surface of V11I d 10 multilayer cultures.
Apical sampling (100 uL) was completed 6 h later for cytokine analyses.
bSelected pro-inflammatory cytokines (top), chemokines (middle) and anti-inflammatory (bottom) cytokines are presented out of the 27 tested using the multiplex array
system. Data are the mean 6 SEM (pg/mL) of 3 replicates from a representative experiment of 3 independent experiments.
cp,0.05 compared to Medium ctrl (Student’s t-test).
dp,0.01 compared to Medium ctrl (Student’s t-test).
ep,0.001 compared to Medium ctrl (Student’s t-test).
doi:10.1371/journal.pone.0032728.t001
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observation of bacterial growth in the highest dilution and then
calculating the viable bacterial load by multiplying by that dilution
factor.
Using this liquid-based quantification system, the viability of L.
crispatus, L. jensenii, L. rhamnosus and L. iners in air-interface VEC
multilayer cultures was evaluated at 24, 48 and 72 h post addition
of bacteria. Interestingly, L. iners did not viably colonize the
multilayers (Figure 3B) indicating an inadequate growth environ-
ment. Viable titers of L. crispatus and L. jensenii (ATCC) and a L.
rhamnosus clinical isolate increased significantly (p,0.05) over the
first 24 h reaching equilibrium for at least an additional 4 d
(Figure 3B & 4A). Together the results indicated that VEC
multilayer cultures supported long-term colonization by several
common vaginal Lactobacilli without observable morphological
changes to the VEC multilayer.
The potential impact of commensal colonization on air-interface
VEC multilayers was evaluated more specifically by measuring cell
health, tight junction integrity and pH changes. L. crispatus
colonization of d 9 V19I multilayers did not significantly (p.0.05)
impact the health of the culture over a 72 h time period (0.260.03
optical density by MTT assay) compared to medium only cultures
(0.260.02). Evaluation of multilayer integrity using TEER
measurements showed no significant (p.0.05) difference between
L. crispatus-colonized cultures (235.362.2 Vcm
2) and controls at
72 h (235.664.7 Vcm
2). Similar outcomes were established for
cultures colonized with L. jensenii. Interestingly, using a pH sensitive
indicator material, neither L. crispatus nor L. jensenii altered the pH of
the apical surface of colonized VEC multilayers relative to non-
colonized cultures (p.0.05; non-colonized pH 7–7.2; L. crispatus
colonized pH 6.8–7.0; L. jensenii pH 7.0–7.2).
Colonization with commensal bacteria altered inducible
cytokine profiles in human VEC multilayers
The impact of colonization by commensal bacteria on VEC
cytokine secretion alone or following recognition of TLR agonists
was evaluated. Initial evaluations were performed to identify
potential cytokine inductions in response to colonization by L.
crispatus, L. jensenii or, as a control, Staphylococcus epidermidis. S.
epidermidis was selected as a non-vaginal commensal control
because it is isolated occasionally from the human vagina [23]
but is more commonly a commensal bacterium of the skin.
Quantification of secreted cytokines showed that L. crispatus or L.
jensenii colonization of VEC multilayer cultures did not signifi-
cantly (p.0.05) alter basal levels of cytokine base on comparison
to levels detected in non-colonized VEC multilayers (Table 2).
Interestingly, colonization of parallel multilayer cultures with S.
epidermidis resulted in a significant (p,0.05) increase in IL-1b, IL-
1ra, IL-8, G-CSF and TNFa (Table 2) relative to non-colonized
cultures. These results correlate with clinical observations that L.
crispatus and L. jensenii colonization does not lead to inflammation
and in fact may reduce proinflammatory cytokine production
[7,9].
To assess the impact of commensal colonization on inflamma-
tion, we treated established VEC multilayers with the selected
TLR agonists in the context of L. crispatus or L. jensenii colonization.
Specifically, PIC or FSL-1 was added apically to triplicate cultures
colonized for 24 h followed by quantification of inflammatory
cytokine production. The induction of cytokines was compared to
non-colonized VEC multilayer controls processed in parallel.
Interestingly, colonization of VEC multilayer cultures with L.
crispatus was associated with a reduction in selected cytokines
induced 24 h after agonist stimulation (Figure 3C and D). PIC
induction of IL-6 and IL-8 was reduced significantly (p,0.05) in L.
crispatus colonized cultures compared to non-colonized cultures
(Figure 3C). Surprisingly, L. jensenii colonized cultures did not show
significant reductions following PIC application although there
was an apparent trend. Similarly, the presence of L. crispatus or L.
jensenii on VEC multilayers significantly reduced (p,0.05) IL-6
and TNFa secretion following FSL-1 stimulation. Other reduc-
tions in cytokine secretion following PIC or FSL-1 were observed
including IL-1ra, IL-12, G-CSF, MIP-1b, and RANTES for L.
crispatus and to a lesser extent L. jensenii (data not shown).
Collectively, these results suggested that L. crispatus colonization
produced a more substantial impact on TLR agonist-induced
cytokine elaboration than L. jensenii, but both bacteria had capacity
to reduce induced inflammatory outcomes.
A clinical isolate of L. jensenii but not other Lactobacilli
spp had pronounced effects on cytokine induction
To address the concern that lab adaptation of the type strain of
L. jensenii affected its ability to colonize or impact the VEC cultures
Figure 2. Commensal bacteria colonized the apical surface of
air-interface VEC multilayer cultures. A. A representative trans-
mission EM micrograph showing the top half of a VEC multilayer culture
24 h post colonization with L. jensenii on the apical surface illustrating
the glycogen vesicles contained in the VEC that increased in size and
density in the apical most layers of the cultures (bar=2 um; 14,1006).
B. Scanning EM micrographs illustrated the apical colonization of L.
jensenii (24 h) and the intimate associations between bacteria and VEC
microvilli present on the surface (bar=2 um; 30006). Apparent
daughter bacterial cells with shorter length as well as areas of higher
bacterial density were observed (inset panel). C. Commensal bacteria
did not associate with the surfaces of cells that were condensed and
apparently sloughing as indicated by their position above the average
plane of the apical surface (e.g. cell left side of image; bar=2 um;
10,0006). D. To confirm the location of the Lactobacilli colonizing the
VEC multilayers, confocal Z-axis projection (636; top panel) and optical
slices (bottom panels in order) from a GFP-expressing VEC multilayer
(green) with DAPI stained nuclei (blue) and antibody labeled L. jensenii
(red) illustrated exclusive superficial colonization of the apical cell
surface. No evidence of bacteria (red labeling) in sections below the
apical surface was obtained even after 72 h of colonization.
doi:10.1371/journal.pone.0032728.g002
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secretions and confirmed their identity and purity through 16 S
ribotyping [24]. In addition to a low passage clinical isolate of L.
jensenii, we also evaluated several L. rhamnosus isolates common to
the vaginal mucosa. Additionally, we isolated L. casei from
commercial yogurt to evaluate the behavior of a non-vaginal
Lactobacillus species in our VEC culture system.
The clinical isolates of L. jensenii and L. rhamnosus as well as L.
casei colonized the VEC multilayers establishing predicted steady
state titers by 120 h post inoculation (Figure 4A). Interestingly, the
low pass clinical L. jensenii isolate colonized cultures more slowly
than the L. jensenii ATCC type strain with a consistent and
significant delay in the establishment of a steady state (figure 4A).
This also was the case for L. casei but not for the clinical L.
rhamnosus isolate that exhibited kinetics similar to the lab adapted
isolates of L. crispatus and L. jensenii (Figure 3B and 4A).
The distinct kinetics and potential for altered interactions with
the VEC multilayer led us to evaluate the impact of each
commensal bacteria on cytokine induction following TLR agonist
exposure over time. This approach also addressed the impact of
differing bacterial titers on the VEC response to the TLR agonist.
For these studies, VEC multilayers were colonized with either the
lab adapted L. jensenii or the clinical isolates for 24 h prior to
addition of FSL-1 (Figure 4B) or PIC (Figure 4C) followed by
sampling 6 h later reproducing our previous study design
(Figure 3). L. casei was included to determine if non-vaginal
Lactobacilli had any impact upon inflammation in our culture
system. After treatment with either of the TLR agonists, even with
100-fold fewer bacteria, the clinical L. jensenii showed significant
tempering of cytokine induction relative to the type strain (Figure 4
panels B and C). The L. rhamnosus isolate had no appreciable
impact on cytokine induction following FSL-1 treatment
(Figure 4B) but had significant impact on selected cytokines after
PIC exposure (Figure 4C). Finally, the non-vaginal L. casei was well
tolerated by the VEC but did not impact cytokine responses
following treatment with either TLR agonist (Figure 4B and C).
The observation that the clinical L. jensenii, even at 100-fold
lower titer, significantly tempered the induction of cytokines led us
to complete a limited time course evaluation comparing the
impact of the type strain and clinical L. jensenii isolates on PIC
cytokine induction. To confirm and extend the prior results, we
also evaluated the impact of the L. crispatus type strain. As shown in
Figure 4 panels D–F, we colonized VEC for either 24 or 48 h
prior to treatment with PIC for 6 or 24 h (24/6, 24/24 or 48/6,
Figure 3. Commensal bacteria colonization kinetics and impact on VEC multilayer cultures. A. A higher-throughput broth-based
bacterial titration system was validated against standard agar plating and subsequent colony counting. Comparison of the two methods showed no
statistical differences in viability quantification (p.0.05, Student’s t-test) supporting subsequent use of the broth-based viability assay. Data are the
mean 6 SEM of duplicate samples from 2 independent experiments. B. Replication kinetics and steady state formation of L. crispatus, L. jensenii or L.
iners (10
3 cfu/well) in VEC multilayer cultures are shown over 72 h. L. iners viability rapidly decreased and no viable bacteria were observed after 24 h.
L. crispatus and L. jensenii viability significantly (*, p,0.05, Student’s t-test) increased after 24 h of culture and was maintained over the study period.
Each time point for the selected bacterial species represents the mean 6 SEM for triplicate wells of each VEC type (V11I, V12I, V19I) from 2
independent experiments. C and D. Colonization of the VEC by L. crispatus and L. jensenii differently impacted responses to TLR agonists (PIC or FSL-
1, respectively) as indicated by the fold change in cytokine levels relative to non-colonized cultures treated in parallel. Data are the mean 6 SEM of 3
replicates from a representative experiment out of 3 independent experiments.
doi:10.1371/journal.pone.0032728.g003
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TLR agonist-induced cytokine expression. A. Colonization kinetics for several vaginal and non-vaginal Lactobacilli are presented over 5 d with
statistically delayed growth for several of the isolates relative to the L. jensenii ATCC type strain (*p,0.05, ANOVA) providing the opportunity to
evaluate the impact of bacterial density on cytokine induction. B and C. Data from the standard paradigm indicated that after 24 h of bacterial
colonization and 6 h of TLR agonist exposure (FSL-1 or PIC, panels B and C, respectively) showed even reduced titers of the indicated Lactobacilli
strains could significantly reduce cytokine induction relative to non-colonized controls treated in parallel (*p,0.05, ANOVA). Colonization with the
clinical L. jensenii (vaginal) isolate that reached 24 h titers ,100-fold lower than the lab adapted isolate (ATCC) produced the most robust reduction
in cytokine expression with more pronounced effects following PIC exposure (panel C). D–F. Given the different kinetics of colonization observed for
each isolate we also kinetically tested selected bacteria for impact on PIC cytokine induction following either 24 or 48 h of colonization. TLR agonist
exposures also were evaluated at two time points (6 and 24 h) creating four testing conditions both confirming and extending the previous
observations. The data are presented as fold change relative to non-colonized cultures treated with PIC in parallel for IL-6 (D), IL-8 (E) and TNFa (F;
*p ,0.05).
doi:10.1371/journal.pone.0032728.g004
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despite establishment of steady state titers within 24 h of seeding,
the tempering of cytokine induction was more pronounced over
time. This suggested that the interaction between bacterial cells
and the apical VEC surface elicited molecular influences in the
bacteria that, in turn, tempered the cytokine response. Transfer of
bacteria from these cultures to fresh cultures required similar
amounts of time to impact VEC responses (data not shown). In
contrast, the L. crispatus type strain had a significant impact on
cytokine induction that was evident at all evaluated time points
confirming the previous results (Figure 3). These results suggested
that any lab adaptations in this isolate were not associated with loss
of the ability to establish relationships with the VEC. Finally, these
data confirmed that the clinical L. jensenii produced the most robust
temperance of responses to PIC even at the lowest bacterial titers
after 24 h of colonization (Figure 4A). The data for all three
bacteria indicate that molecular contributions of the particular
isolate during the process of colonization of the VEC was more
important to the impact on cytokine induction than actual titer of
the commensal organism.
Discussion
Although the clinical importance of the vaginal microbiome has
been well established [7], the molecular basis of the contribution of
these bacteria has been understudied because of poor animal and
in vitro model systems. Many approaches for modeling the human
vaginal mucosa have been developed with differing success but
collectively the current systems lack the ability to reproducibly
recapitulate the complexity of the stratified squamous epithelium.
To date none of the culture systems have created a useful apical
surface with an air interface where commensal and pathogenic
bacteria can properly colonize. We report a refined transwell
culture system using immortalized VEC [21] that created
polarized and differentiated multilayers with an apical surface
environment adequate for colonization by selected common
vaginal Lactobacilli. We report different capabilities of both lab
adapted and low passage clinical isolates of common vaginal
Lactobacilli spp. to colonize and impact these cultures; a novel
paradigm for classification of these important bacterial strains.
Lactobacilli spp. colonization was well tolerated by our VEC
multilayers but colonization by S. epidermidis led to inflammatory
cytokine responses indicating the cultures retained the ability to
distinguish common commensal species from transient organisms
not normally present in the vaginal microbiome. Although our
culture system offered substantial improvements, it was unable to
support sustained colonization by the common vaginal commensal
L. iners suggesting additional refinements are still needed to better
support this fastidious organism.
The multilayer air-interfaced VEC culture system facilitated
development of a stratified, squamous epithelium with relevant
characteristics including basal progenitor cells and anucleate cells
at the apical surface that appeared to be separating from the
deeper, nucleated layers similar to that seen in vivo (Figure 1). The
value of such a culture is substantial because of the distinct
differences in vaginal tissues in animal models. For example, the
commonly used rabbit vaginal irritation model, that is Food and
Drug Administration approved for evaluating the safety of
vaginally-applied compounds [25], lacks stratified squamous
epithelium and in fact is primarily composed of columnar
epithelial cells [26]. Non-human primate, sheep and pig models
provide an improved representation of the human vaginal mucosa
[27,28,29,30,31,32] but experiments involving these large animals
are expensive and animal availability is limited. Rodent models
also have been used commonly to evaluate the activity and safety
of vaginally-applied compounds [30,33,34,35].
Unfortunately, the distinct physiological differences in the vaginal
environment of each of the animal models including distinct
microbiomes limit their utility to address the impact Lactobacilli
common to the human vagina [27,36,37,38]. Zarate and colleagues
placed the probiotic L. paracasei (CRL 1289) in murine vaginal tracts
showing that this probiotic transiently colonized the mouse vagina
and reduced titers of uropathogenic S. aureus [39]. Utilizing more
common vaginal commensals, Jerse and her colleagues also
evaluated murine vaginal colonization with L. jensenii [40] and in
a later report L. crispatus [41]. Although colonization by either
bacterium was transient after a single application, using two
inoculations of L. crispatus the group was able to establish sustained
vaginal colonization [41]. With this success, it is possible that the
mouse could be conditioned to provide a supportive environment
for human vaginal commensals but additional work is needed to
refine the method for colonization with other Lactobacilli.
Human explant models have been developed using tissues
obtained during hysterectomies but have shown intra- and inter-
subject variability and are limited to available donors and the
amounts of tissue collected [42]. The cultures also are sterile and
are relatively short-lived with minimal capacity for follow up
studies in the same genetic background. While organotypic
cultures generated from primary ectocervical/vaginal cells are
commonly and now even commercially available, they are
expensive, are limited in supply, are associated with substantial
biological variation, lack an air interface and do not include
commensal bacteria. Recent advances with bioreactors using
rotating wall vessel technology [43] have produced solid
alternatives to existing culture systems but lack defined basal and
apical chambers and importantly do not include the option for an
air interface at the mucosal surface.
Utilizing our refined VEC multilayers we first determined that
selected bacterial species colonized rather than replicated in an
unrestricted fashion in the cultures. Previous experiments with
Table 2. VEC multilayer cultures selectively responded to
non-vaginal commensal bacteria.
Cytokine
b Medium ctrl Commensal Bacteria
a
L. jensenii L. crispatus S. epidermidis
IL-1b 12637 611 0 614 3 69
c
IL-6 11611 6 631 5 623 1 613
IL-8 96611 83661 6 6 624 10586107
c
IL-12(p70) 40644 0 633 4 633 5 65
TNFa 22642 4 631 7 62 131647
d
G-CSF 58616 37677 6 629 131618
d
GM-CSF 7617 618 621 8 64
MIP-1b 5626 626 627 61
RANTES 55621 54616 51617 155673
IL-1ra 984461943 1145362083 1034363372 3165367806
d
aL. jensenii (1000 cfu), L. crispatus (1000 cfu), S. epidermidis (1000 cfu) or a
medium control (ctrl, 10 uL) was added to the apical surface of V11I d 9
multilayer cultures. Apical sampling (100 uL) was completed 6 h later for
cytokine analyses.
bSelected cytokines are presented. Data are the mean 6 SEM (pg/mL) of 3
replicates from a representative experiment of 3 independent experiments.
cp,0.001 compared to medium ctrl (Student’s t-test).
dp,0.05 compared to medium ctrl (Student’s t-test).
doi:10.1371/journal.pone.0032728.t002
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bacteria [44] or live bacteria within an 8 h time period [14] and
did not provide effective modeling of the bacterial VEC interface.
In our colonized VEC multilayer cultures, viable bacteria were
recoverable up to at least 5 d post addition of bacteria and
importantly they established a steady state of colonization similar
to levels predicted by bacterial load estimations from clinical
specimens [8]. No impact on cell health and tight junction
integrity was observed following bacterial colonization indicating a
symbiotic relationship is established between the bacteria and the
VEC. In support of symbiosis between the VEC and bacteria,
glycogen and mucin containing vesicles were plentiful throughout
the VEC layers but higher concentrations in the more apical layers
of the cultures were visualized where the bacteria localized
(Figure 1B). Such vesicles likely contributed to successful
Lactobacilli colonization because glycogen is utilized by Lactoba-
cilli for metabolic functions including the production of lactic acid
that contributes to the acidic pH of the vaginal surface [7]. In our
studies, each of the L. jensenii and L. crispatus isolates produced
lactic acid when grown axenically (MRS broth culture pH was
shifted from 6.0 to less than 4.0 after 18 h of culture). Despite this
finding, colonization did not lead to detectable VEC surface pH
changes even after multiple approaches were attempted. The lack
of a pH shift in the culture environment most probably reflects the
substantial buffering capacity of the culture medium in the basal
chamber. It is notable that the health of the VEC was negatively
impacted when the pH of the medium became acidic in the
absence of bacteria.
In addition to different species of commensal bacteria, the
observed differential rates of colonization by lab adapted and
clinical Lactobacilli isolates led us to study the impact of the
bacteria on VEC behavior using multilayers created in 96 well
formats. Studies of other Lactobacilli in the context of intestinal
mucosal colonization have suggested that these bacteria can create
anti-inflammatory signals in host cells with which they associate
[45,46]. We tested the hypothesis that appropriate commensal
bacteria might alter innate immune responses as indicated by
cytokine production following a controlled insult from a TLR
agonist as reported previously [21]. Colonization of VEC
multilayers with L. jensenii and L. crispatus isolates differentially
tempered pro-inflammatory outcomes. The lab-adapted L. jensenii
isolate (ATCC 25258) retained the ability to modulate inflamma-
tion but this effect required prolonged colonization of the VEC
despite the most robust replication of the bacteria after culture
inoculation. This trait was not retained after subculture to another
VEC multilayer (data not shown) suggesting that transient
bacterial transcriptome and/or proteome changes were responsi-
ble for impact on VEC. This is an ongoing area of research that
will capitalize on the differences observed between the clinical and
lab-adapted strains. In contrast, non-vaginal Lactobacilli failed to
alter VEC responses to the tested TLR agonists despite effective
colonization indicating that the VEC environment did not create
the specific molecular relationships for these isolates.
Establishing molecular mechanisms for the commensal micro-
biome’s contribution to vaginal health is crucial to improved
topical drug and vaccine development as well as basic under-
standing of commensal bacterial contributions to tissue develop-
ment. Chronic elaboration of pro-inflammatory cytokines has
been linked with disruption of the integrity of the vaginal mucosa
and activation of HIV in infected individuals [47]. The S.
epidermidis isolate tested in our study induced an inflammatory
cytokine response profile that was similar to that observed for
women with bacterial vaginosis (BV) [16,48,49,50]. BV is a
polymicrobial condition characterized by replacement of Lacto-
bacilli with anaerobic bacteria [51]. This leads to a state of acute
or persistent mucosal inflammation and is associated with increase
susceptibility to STI [16,48,52]. In the VEC multilayer cultures,
Lactobacilli colonization significantly reduced IL-6, IL-8 and
TNFa secretion after TLR stimulation supporting the hypothesis
that, in vivo, the presence of BV bacteria and the absence of
commensals may combine to produce elevated inflammation.
Additional model refinements will be necessary to address this
hypothesis but the current data are consistent with that conclusion.
The role of commensal bacteria in mucosal health is an area of
intense research and recent studies have indicated the remarkable
impacts of these bacteria on tissue development, immunity, as well
as systemic effects on tissues distant to the sites of colonization
[53]. Study of the molecular interactions between commensal
bacteria and the vaginal mucosa will likely reveal novel avenues for
probiotic development as well as improved systems for vaginally
applied compounds to enhance resistance to infections. We believe
that our culture system offers an important advance for such
experiments as evidenced by these first observations that indicate
an inflammatory temperance effect is provided by stable
colonization with relevant commensal bacteria. This novel in
vitro model is widely adaptable for evaluating other important
biological questions such as the impact of commensals on STI
acquisition prior to or just after antimicrobial treatment. Others
have suggested the use of Lactobacilli probiotics in treatments for a
variety of vaginal infections including BV [54] and, through
genetic modification of probiotic Lactobacilli strains, specific STI
including HIV [55]. It is clear that a delicate balance of bacterial
species is associated with normal vaginal health [11,56] but
additional investigations are needed to determine the optimal
profile of species and ratios for probiotic treatments to succeed.
We believe that this VEC culture system is a reliable, reproducible
platform to perform such evaluations. Importantly, our data
suggest that testing of vaginally applied compounds in the context
of commensal bacteria will provide a more informative and
predictive measure of success prior to clinical evaluations.
Methods
Air-interface Multilayer Culture Model
Human immortalized VEC from 3 donors (V11I, V12I, V19I)
were cultured as described previously [21]. The human VEC
multilayer cultures were generated by addition of VEC (1610
5
cells) in antibiotic-free, keratinocyte serum-free medium (KSFM;
Invitrogen, Carlsbad CA) to the top chambers of 96 well insert
system in an angled bottom plate (Becton, Dickinson and
Company; (BD) Franklin Lakes, NJ) containing 260 uL of KSFM
in the bottom chambers. Cultures were incubated for 24–36 h
before the medium from the top chamber was removed to form
the air-interface. Medium in each bottom chamber was replaced
every other day. Trans-epithelial electrical resistance (TEER;
World Precision Instruments, Sarasota, FL) values are reported as
the mean of 3 culture inserts 6 SEM for each time point. Cultures
were considered mature based on TEM, SEM and TEER
evaluations at day 7–9 after plating. Prior to the start of any
experiment, fresh medium was added to the bottom chamber.
Bacterial Culture, Colonization of Multilayer Cultures and
Viability Quantification
Bacteria were subcultured in De Man, Rogosa, Sharpe (MRS)
broth (BD) for Lactobacillus jensenii (ATCC 25258) and Lactobacillus
crispatus (ATCC 33820) or Tryptic Soy (TS) broth (BD) for
Staphylococcus epidermidis (ATCC 35984) then stored at 280uCi n
bacterial specific medium with 15% glycerol (Fisher, Pittsburgh,
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provided by Bernard Moncla) were subcultured on chocolate agar
plates (PML, Wilsonville, OR) in anaerobic conditions using Bio-
Bags (BD) then stored at 280uC in Litmus Milk (BD).
VEC multilayer cultures (d 9) apical surfaces were inoculated
with log phase bacteria prepared fresh before each study. Frozen
bacterial aliquots were thawed into 5 mL of MRS broth for L.
jensenii and L. crispatus or TS broth for S. epidermidis and cultured at
37uC for 18 h in a sealed 15 mL conical tube (BD). After 18 h, the
number of viable bacteria present was quantified by plating of
serial 10-fold dilutions onto MRS or TS agar plates (BD) or by the
liquid-based quantification assay. For the liquid-based quantifica-
tion assay, MRS or TS broth (90 uL) was added to all wells of a 96
well culture plate (BD) and 10 uL of the bacterial stock was added
to the first column. Serial 10-fold dilutions into the remaining 11
columns were performed subsequently. The plates were incubated
for 24 h then visually inspected using an Axiovert 25 microscope
(Zeiss, Thronwood, NY) at 206magnification to identify the last
well that contained bacteria. Based on these serial dilutions, the
approximate cfu/mL of each bacteria present in the tubes after
18 h of growth was calculated. This system also was used for
quantifying bacterial loads in the VEC multilayer cultures through
triplicate platings. Standard agar plating was directly compared to
the liquid-based quantification to confirm the validity of this
higher-throughput approach (Figure 3A).
To prepare L. iners, a frozen stock was thawed and then cultured
for 48 h on chocolate agar plates anaerobically. After 48 h, the
bacteria were scraped from the plate into sterile PBS, and the amount
of viable bacteria present was quantified using serial dilutions on
chocolate agarplates.All bacteria were pelleted and washed extensively
before final suspension into KSFM prior to VEC inoculation.
To quantify long-term bacterial viability in the multilayer cultures
and the impact of bacteria on VEC health, 1000 cfu of selected
bacteria (10 uL) or KSFM (10 uL) was added to the apical air-
interface. The cultures were incubated for up to 5 d and at selected
times 50 uL of KSFM was added to the top chamber followed by
mechanical disruption of the multilayer. After mixing to create a
suspension of material, two 10 uL aliquots of the sample were
subjected to bacterial titration using the broth-based viability
analysis. The remaining 30 uL of sample was analyzed via MTT
assay using 1 mg/mL Thiazolyl Blue Tetrazolium Bromide to assess
cell health (Sigma, St. Louis, MO). MTT values were collected on a
Versamax microplate reader (560 nm; Molecular Devices; Sunny-
vale, CA). Changes in apical cell surface pH were measured in
triplicate wells using pH 4.0–8.0 indicator strip material (EMD,
Gibbstown, NJ) at 6, 18 and 24 h post addition of the bacteria.
Histological Staining and Immunofluorescent Labeling
VEC multilayer cultures (d 9) were fixed with Z-fix (Anatech,
Battle Creek, MI) for 24 h at 4uC. The filters were excised, paraffin
embedded and 5 um sections were cut using a Microm HM 310
microtome (Fisher, Pittsburgh, PA) prior to mounting on slides. The
sections were hematoxylin and eosin (H&E) or periodic acid Schiff
(PAS) stained to visualize the cell layers or glycogen deposits,
respectively. For confocal observation of multilayer formation, the
cultures were Z-fixed and washed 3 times with tris-buffered saline
(Fisher) then the filters were excised and mounted on slides. Cells
were labeled using Vectashield with DAPI (Vector Laboratories,
Burlingame, CA) prior to visualization on a LSM 510 UV Meta
Laser Scanning Confocal Microscope (Zeiss).
To observe bacterial colonization of the apical cell surface,
1000 cfu of selected bacteria were added to d9 GFP-expressing
V19I cultures. After 24 or 72 h the fixed culture inserts were
labeled with a monoclonal antibody recognizing the lipoteichoic
acid of Gram+ bacteria (clone 3801; Santa Cruz Biotechnology,
Santa Cruz, CA) and a goat anti-mouse secondary conjugated to
AF555 (Invitrogen). Filters were removed, mounted using
Vectashield with DAPI and visualized by confocal microscopy.
Transmission, Immunogold Occludin-Labeling and
Scanning Electron Microscopy
VEC multilayer cultures (d 9) 24 h post addition of medium
controls or 1000 cfu of selected bacteria were Z-fixed and used for
electron microscopy (EM) experiments. Cultures were rinsed with
cacodylate buffer, postfixed in 1% OsO4 in 0.1 M cacodylate
buffer for non immunogold EM samples, rinsed with water,
stained en bloc with 2% aqueous uranyl acetate and dehydrated in
ethanol. Filters were excised and embedded in Poly-Bed 812 resin
(Polysciences Inc., Warrington, PA) or LR White (Electron
Microscopy Sciences, Hatfield, PA) for immunogold EM samples.
Ultrathin sections were cut on a Leica EM UC7 ultramicrotome
(Leica Microsystems, Bannockburn, IL) then labeled with rabbit
anti-human occludin (Santa Cruz Biotechnology, Santa Cruz, CA)
and a 15 nm gold-labeled goat anti-rabbit IgG (Aurion, Electron
Microscopy Services). Sections were stained with lead citrate then
examined on a Philips CM100 TEM at 60 kV.
For scanning EM, the cultures were fixed as above then
dehydrated in ethanol and processed through hexamethyldisala-
zane followed by air-drying. The filters were excised, mounted
onto metal stubs and sputter-coated with iridium in an Emitech
K5756 Sputter Coater (Emitech, Houston, TX) at 20 mA for
20 sec. The filters were examined in a Hitachi S4700 SEM
(Hitachi High Technologies, Schaumburg, IL) at 2 kV.
TLR Agonists and Cytokine Quantification
Synthetic TLR agonists (Invivogen; San Diego, CA) tested were
peptidoglycan (PGN,TLR2),fibroblaststimulatingligand-1 (FSL-1,
TLR2/6) and polyinosinic:polycytidylic acid (PIC, TLR3). Recom-
binant Salmonella dublin flagellin (FLAG, TLR5) was produced and
purified as previously described [57]. For TLR agonist treatments,
VEC multilayer cultures were incubated for indicated periods of
time with 1000 cfu of selected bacteria or KSFM. After 24 h, PIC
(0.1 mg/mL), FSL-1 (0.1 ug/mL), FLAG (5 ug/mL), PGN
(0.1 mg/mL) or KSFM (10 uL) was added to the apical surface.
After 6 or 24 h, 100 uL of medium was added to the apical surface
and gently moved over the surface by pipeting simulating a vaginal
lavage before being collected and stored at 280uC. Culture lavages
(50 uL) were evaluated using the BioPlex Human Group I cytokine
kit (Bio-Rad, Hercules, CA) following the recommendations of the
manufacturer. Absolute cytokine quantities (pg/mL) were extrap-
olated from a standard curve run in parallel.
Statistical Analyses
Data were analyzed for significance with the Student’s t-test
using the Prism software package v4.0 (Graph Pad, San Diego,
CA). Each study was repeated at least once with triplicate samples
to confirm results.
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